Remove Biopharma Remove Doctors Remove Medical science
article thumbnail

Amgen and Pfizer appoint new Science executives

European Pharmaceutical Review

Prior to his work in the biopharma industry, Dr Boshoff was founding Director of the University College London (UCL) Cancer Institute. He earned his medical degree from University of Pretoria in South Africa, a doctorate PhD from the Institute of Cancer Research in London. Academy of Medical Sciences. “I

article thumbnail

Precision Medicine Requires Opportunities to Connect with Patients

PM360

When Marc’s doctors discovered he had a rare liver condition, it almost felt like a relief. Combined with the incentives provided by the Orphan Drug Act, a powerful dynamic is at play, ever further pushing the limits of what medical science can achieve. At least his enemy now had a name. Piecing the Fragments Together.

article thumbnail

Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile

Clarify Health

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.).